A 58-year-old man with cirrhosis (Child-Pugh B) undergoes imaging for suspected hepatocellular carcinoma. Which single imaging feature best distinguishes HCC from benign regenerative nodules in cirrhotic livers?

Question

Accepted Answer

B. Arterial phase hyperenhancement followed by washout in portal venous or delayed phase. ## Imaging Diagnosis of HCC in Cirrhosis

### Hallmark Enhancement Pattern

**Key Point:** The pathognomonic imaging feature of HCC in a cirrhotic liver is **arterial phase hyperenhancement (APHE) followed by washout** in the portal venous or delayed phase. This pattern reflects the dual blood supply shift in HCC — increased hepatic artery contribution and loss of portal venous inflow.

### Mechanism Behind the Pattern

In cirrhotic livers:
- Normal hepatocytes receive 75% blood from portal vein, 25% from hepatic artery
- Early HCC nodules develop increased arterial supply (angiogenesis) while retaining some portal venous flow
- As HCC progresses, portal venous supply diminishes → arterial dominance
- The washout occurs because HCC lacks the reticuloendothelial system present in normal liver

### Diagnostic Criteria (AASLD/EASL)

| Nodule Size | Diagnostic Criteria |
|---|---|
| >20 mm | APHE + washout on one imaging modality (CT/MRI) |
| 10–20 mm | APHE + washout on both CT AND MRI, OR biopsy |
| <10 mm | Follow-up imaging (too small for reliable diagnosis) |

**High-Yield:** Nodules showing APHE alone (without washout) are **not diagnostic** of HCC — they require either a second imaging modality or biopsy confirmation.

### Why Other Patterns Are Non-Specific

- **Homogeneous arterial enhancement** alone occurs in both HCC and benign hyperenhancing nodules (adenomatous hyperplasia)
- **Iso-attenuation** is typical of regenerative nodules and is reassuring
- **Rim enhancement** suggests advanced HCC or cholangiocarcinoma, not early HCC

**Clinical Pearl:** In a cirrhotic patient with a 15 mm nodule showing APHE on CT, you MUST obtain MRI with hepatobiliary contrast (gadoxetate) to confirm washout before diagnosing HCC.

[cite:Robbins 10e Ch 20]

![Hepatocellular Carcinoma diagram](https://mmcphlazjonnzmdysowq.supabase.co/storage/v1/object/public/blog-images/explanation/3091.webp)

Answer

A. Peripheral rim enhancement with central hypoenhancement

Answer

C. Homogeneous enhancement in the arterial phase

Answer

D. Iso-attenuation to liver parenchyma on all phases

A 58-year-old man with cirrhosis (Child-Pugh B) undergoes imaging for suspected hepatocellular carcinoma. Which single imaging feature best distinguishes HCC from benign regenerative nodules in cirrhotic livers?

Explanation

Imaging Diagnosis of HCC in Cirrhosis

Hallmark Enhancement Pattern

Mechanism Behind the Pattern

Diagnostic Criteria (AASLD/EASL)

Why Other Patterns Are Non-Specific

Practice similar questions

Join our NEET PG community

Nodule Size	Diagnostic Criteria
>20 mm	APHE + washout on one imaging modality (CT/MRI)
10–20 mm	APHE + washout on both CT AND MRI, OR biopsy
<10 mm	Follow-up imaging (too small for reliable diagnosis)